4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-25-032908
Options or other derivatives
- Chief Legal Officer acquired 144,751 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tousignant Jennifer Chief Legal Officer | 2025-03-03 | Grant or award · Stock Option (Right to Buy) | +124,072 | 124,072 | D | ||
| Tousignant Jennifer Chief Legal Officer | 2025-03-03 | Grant or award · Restricted Stock Units | +20,679 | 20,679 | D | ||
Loading xslF345X05/ownership.xml…